You are currently browsing the category archive for the ‘Uncategorized’ category.
Picking up warm lumps of dog crap is one of the reasons I won’t have a dog until I have enough property so to make the necessity mute.
So hats off to all those dog owners who do pick up the doo. Well, except for that population that willfully picks up their dogs poop with a plastic bag, and then, for some god forsaken reason drops that plastic bag of ship somewhere else. Example: there are bags of dog shit hanging from the trees at my daughters elementary school. Oh, and not just one bag, but two, like the first time the throwing of the bags into the woods and got stuck in the tree would never happen again.
So to those who like to pick up dog shit with a plastic bag and then move it to another place just to drop it in a new public place but now surrounded with plastic, just leave the shit where it lay and save us all from one more plastic bag of shit.
“Fuckupitable” is used in a situation that can become “Fucked Up” but if done correctly is fine.
Used in a sentence: “Wow- that was Fuck-upitable- Driving across that bridge that was all ice and had no guardrails! Dam I am good…”
Drug patents, International Conflict and Your Best Interest (Oh My)
Years ago Brazil went out on a limb and “Stole” medicine (patents) and delivered end product to their population. When we think about patents that have a significant implication to the world, at what point does recouping development costs and making a little profit become overshadowed by long term corporate greed and our planets / populations best interest?
The argument is simple enough. If companies that invest and develop drugs are not compensated then these ideas will never be created and those who need the medicine will never receive it. This possibly used to be true but it is no longer a fact.
A person who used to work for the largest of drug companies shared with me that it often costs a company up to Two Billion Dollars to bring a new drug to market. Granted, these costs also include the research to find out if the new drug would cannibalize any of the existing medicine revenue they currently sell.
Case in point- this same company researched creating their own brand of Cannabis / THC and discovered that besides not being able to create a ‘Unique Product’ that what they did create showed higher than acceptable percentages of pregnant women having ‘Ecstatic Births’. Can’t have that! Think of all the meds our hospitals feed our mothers and how much money that generates. Not to mention that the United States is among the LAST on the list for healthy births for developed nations. “The Business of Being Born” does a great job of explaining the downward drug loop that precipitates this unfortunate fact.
So what can be done? The idea is simple enough; Open Source Drug Development. Allow for meaningful co-development to occur and credit those who have impact on the end result. Spread out the costs, leverage the brain power of the ‘Crowd’ (reference Ted Talk: Of oxes and the wisdom of crowds: Lior Zoref at TED2012). http://blog.ted.com/2012/02/29/of-oxes-and-the-wisdom-of-crowds-lior-zoref-at-ted2012/
Collaborative research is now longer outside our abilities. I imagine we will begin to see this type of research done as plant based medicines ( which may not provide the revenues necessary to sole source research ) still provide critical efficacy.
CBD (Cannabidiol) is a good example candidate. ( PS: The U.S. Federal Government has the patent on Cannabidiol. )
The below is the referenceable point that inspired this idea.
The average annual cost of ART per patient in 1997 was $4,459—compared to over $10,000 in most of the developed world—totaling only $242 million per annum. However, in 2001, Brazil manufactured locally 8 of the 12 drugs in the national ARV cocktail; in 2003 and 2005, 8 of the 15. If all of the drugs were patented imports, the cost of these ARV programs would increase by 32%. In the period between 1996 and 2000, Brazil reduced treatment costs by 72.5% through import substitution; by contrast, the price of imports dropped by only 9.6%. Brazil has save over US $1.1 billion in the cost of providing universal access to ART by producing anti-retroviral medications generically 
Article 71 of the 1997 Brazilian patent law requires that foreign products be manufactured in Brazil within three years of receiving a patent. If a foreign company does not comply, Brazil may authorize a local company to produce the drug without the consent of the patent holder, a tactic known as “compulsory licensing” or the “bargaining chip and as a last resort.” In addition, Article 68 authorizes “parallel importing” from the lowest international generic bidder, effectively destroying the patent holder’s monopoly as well.
Prodded by domestic pharmaceutical lobbies, the U.S. challenged Article 68 within the framework of the World Trade Organization‘s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) regime for allegedly discriminating against imported products; Article 71—to the chagrin of many companies—was not included in the complaint. In additional, the U.S. placed Brazil on the “Special 301” watch list, opening the possibility for “unilateral sanctions,” and companies individually threatened to pull out of the Brazilian market altogether. Brazil argued that the law only applied to cases where the patent holder abuses their economic power, a loophole specifically allowed by the TRIPS agreement. Advocates of intellectual property rights (IPR) worldwide condemned the actions of the Brazilian government. For example, Slavi Pachovski, a member of the Institute for Trade, Standards and Sustainable Development, argues:
- If this trend proceeds, it will be a global pandemic of AIDS that will grow uncontrollable because the Brazilian move will destroy the whole legal order that is the basis for developing new drugs and continuing research.
The pharmaceutical companies were not just afraid of the immediate loss of the Brazilian market, but with the larger implications of other developing countries following Brazil’s example. Large developing countries, like Argentina and India, with large industrial capacities and evolving intellectual property regimes are the true elephant in the room.
You have had some really fantastic ideas – and then… nothing. What a shame to let your inspiration go without a chance. For some of us this happens frequently. Sometimes with good reason – too busy, doesn’t fit our strengths, we personally don’t care. Well whatever the reason, there is someone out there who does care about your idea, it does fit their strengths and they have the resources to make that idea come true.
Kicking it all off I will post ideas here: Some ideas will not be amazing or possibly down right silly, however some may also be significant to us all.
RTT ( Roberts Think Tank ) we will cover ideas from the simple gadget, new phrases for a changing world, or take on old entrenched ideas like ‘There is not enough in the world so we should hoard all we can’. Yuck. In contrast, when we work together we are more powerful and there is enough.
If you have not got the memo, Big Business / AKA the ‘Corporate Person’ is not going to take care of you and me or the world we live in; that is up to us.
So browse. Take action on what you like or offer suggestions. When an idea from the community does work out great, let those who you found to be truly inspiring know.
Peace and Prosperity